Kanuka honey versus aciclovir for the topical treatment of herpes simplex labialis: a randomised controlled trial.
aciclovir
cold sore
herpes simplex labialis
kanuka honey
pragmatic trial
randomised controlled trial
Journal
BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874
Informations de publication
Date de publication:
14 05 2019
14 05 2019
Historique:
entrez:
17
5
2019
pubmed:
17
5
2019
medline:
12
5
2020
Statut:
epublish
Résumé
To compare New Zealand medical grade kanuka honey with topical aciclovir for the treatment of herpes simplex labialis. Prospective parallel randomised controlled open-label superiority trial. 76 community pharmacies across New Zealand between 10 September 2015 and 13 December 2017. 952 adults randomised within the first 72 hours of a herpes simplex labialis episode. Random assignment 1:1 to either 5% aciclovir cream or medical grade kanuka honey (90%)/glycerine (10%) cream, both applied five times daily. The primary outcome was time from randomisation to return to normal skin (stage 7). Secondary outcomes included time from randomisation to stage 4 (open wound), time from stage 4 to 7, maximal pain, time to pain resolution and treatment acceptability. Primary outcome variable: Kaplan-Meier-based estimates (95% CI) for the median time in days for return to normal skin were 8 (8 to 9) days for aciclovir and 9 (8 to 9) for honey; HR (95% CI) 1.06 (0.92 to 1.22), p=0.56. There were no statistically significant differences between treatments for all secondary outcome variables. No related serious adverse events were reported. There was no evidence of a difference in efficacy between topical medical grade kanuka honey and 5% aciclovir in the pharmacy-based treatment of herpes simplex labialis. ACTRN12615000648527;Post-results.
Identifiants
pubmed: 31092654
pii: bmjopen-2018-026201
doi: 10.1136/bmjopen-2018-026201
pmc: PMC6530412
doi:
Substances chimiques
Antiviral Agents
0
Acyclovir
X4HES1O11F
Banques de données
ANZCTR
['ACTRN12615000648527']
Types de publication
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e026201Informations de copyright
© Author(s) (or their employer(s)) 2018. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: RB reports grants from HoneyLab, during the conduct of the study; grants and personal fees from GlaxoSmithKline, outside the submitted work. All other authors declare: no support from any organisation for the submitted work; no financial relationships with any organisations that might have an interest in the submitted work; no other relationships or activities that could appear to have influenced the submitted work.
Références
JAMA Oncol. 2017 Jun 1;3(6):738-739
pubmed: 27658006
J Tradit Complement Med. 2014 Jan;4(1):24-35
pubmed: 24872930
Curr Opin Virol. 2014 Oct;8:54-61
pubmed: 25036916
Immunopharmacol Immunotoxicol. 2012 Aug;34(4):598-607
pubmed: 22212104
BMJ Clin Evid. 2009 Sep 23;2009:
pubmed: 21726482
N Z Med J. 2009 May 22;122(1295):47-60
pubmed: 19648986
Arch Virol. 2017 Sep;162(9):2539-2551
pubmed: 28547385
Arch Med Res. 2014 Jul;45(5):359-65
pubmed: 24880005
BMJ Open. 2015 Jun 24;5(6):e007651
pubmed: 26109117
Food Chem. 2017 Dec 15;237:214-224
pubmed: 28763988
Clin Trials. 2016 Apr;13(2):117-26
pubmed: 26908540
Lancet. 2005 Jan 1-7;365(9453):82-93
pubmed: 15639683
Iran J Basic Med Sci. 2013 Jun;16(6):731-42
pubmed: 23997898
Cochrane Database Syst Rev. 2015 Mar 06;(3):CD005083
pubmed: 25742878
Transl Biomed. 2012;3(2):
pubmed: 22822475
BMJ Open. 2017 Aug 3;7(8):e017766
pubmed: 28775197
Wound Repair Regen. 2014 Mar-Apr;22(2):187-92
pubmed: 24612472
J Eur Acad Dermatol Venereol. 2017 Sep;31(9):1440-1446
pubmed: 28449377
Med Sci Monit. 2004 Aug;10(8):MT94-8
pubmed: 15278008
Antimicrob Agents Chemother. 2002 Jul;46(7):2238-43
pubmed: 12069980
Wounds. 2014 Feb;26(2):47-54
pubmed: 25860226
Ochsner J. 2012 Spring;12(1):45-56
pubmed: 22438782
J Am Acad Dermatol. 2015 Sep;73(3):525-6
pubmed: 26282802
Pharmacoeconomics. 2015 Nov;33(11):1195-214
pubmed: 26068945
Wounds. 2015 Jun;27(6):141-51
pubmed: 26061489
Antiviral Res. 2014 Nov;111:36-41
pubmed: 25218782
J Altern Complement Med. 1996 Fall;2(3):345-8
pubmed: 9395668